NIU TECHNOLOGIES-SPONS ADR (NIU)

US65481N1000 - ADR

1.76  +0.03 (+1.73%)

After market: 1.75 -0.01 (-0.57%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NIU. NIU was compared to 42 industry peers in the Automobiles industry. NIU has a bad profitability rating. Also its financial health evaluation is rather negative. NIU is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

NIU had negative earnings in the past year.
In multiple years NIU reported negative net income over the last 5 years.
In multiple years NIU reported negative operating cash flow during the last 5 years.

1.2 Ratios

NIU has a Return On Assets of -12.41%. This is comparable to the rest of the industry: NIU outperforms 54.76% of its industry peers.
Looking at the Return On Equity, with a value of -24.85%, NIU is in line with its industry, outperforming 54.76% of the companies in the same industry.
Industry RankSector Rank
ROA -12.41%
ROE -24.85%
ROIC N/A
ROA(3y)-1.71%
ROA(5y)3.32%
ROE(3y)-3.59%
ROE(5y)6.04%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NIU's Gross Margin of 21.53% is amongst the best of the industry. NIU outperforms 80.95% of its industry peers.
NIU's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NIU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y9.88%

3

2. Health

2.1 Basic Checks

NIU does not have a ROIC to compare to the WACC, probably because it is not profitable.
NIU has more shares outstanding than it did 1 year ago.
NIU has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NIU has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.09, we must say that NIU is in the distress zone and has some risk of bankruptcy.
NIU's Altman-Z score of 1.09 is fine compared to the rest of the industry. NIU outperforms 66.67% of its industry peers.
NIU has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
NIU has a Debt to Equity ratio of 0.24. This is in the better half of the industry: NIU outperforms 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACCN/A
WACC8.94%

2.3 Liquidity

A Current Ratio of 1.64 indicates that NIU should not have too much problems paying its short term obligations.
With a Current ratio value of 1.64, NIU perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
NIU has a Quick Ratio of 1.28. This is a normal value and indicates that NIU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.28, NIU is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.28

5

3. Growth

3.1 Past

NIU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -441.71%.
The Revenue for NIU has decreased by -16.31% in the past year. This is quite bad
The Revenue has been growing by 12.40% on average over the past years. This is quite good.
EPS 1Y (TTM)-441.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.48%
Revenue 1Y (TTM)-16.31%
Revenue growth 3Y2.75%
Revenue growth 5Y12.4%
Sales Q2Q%16.03%

3.2 Future

NIU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.09% yearly.
The Revenue is expected to grow by 16.04% on average over the next years. This is quite good.
EPS Next Y53.85%
EPS Next 2Y41.45%
EPS Next 3Y21.09%
EPS Next 5YN/A
Revenue Next Year15.03%
Revenue Next 2Y19.63%
Revenue Next 3Y16.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

NIU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 4238.84, NIU can be considered very expensive at the moment.
NIU's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NIU is cheaper than 71.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, NIU is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 4238.84

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NIU does not grow enough to justify the current Price/Earnings ratio.
NIU's earnings are expected to grow with 21.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.45%
EPS Next 3Y21.09%

0

5. Dividend

5.1 Amount

No dividends for NIU!.
Industry RankSector Rank
Dividend Yield N/A

NIU TECHNOLOGIES-SPONS ADR

NASDAQ:NIU (12/20/2024, 9:23:23 PM)

After market: 1.75 -0.01 (-0.57%)

1.76

+0.03 (+1.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-18 2024-11-18/bmo
Earnings (Next)N/A N/A
Inst Owners11.4%
Inst Owner Change-10.18%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap136.57M
Analysts76.67
Price Target2.4 (36.36%)
Short Float %3.01%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.63%
PT rev (3m)14.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-663.26%
EPS NY rev (3m)-663.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-11.3%
Revenue NY rev (3m)-11.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4238.84
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)0
Fwd EY0.02%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.68
BVpS1.93
TBVpS1.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.41%
ROE -24.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.53%
FCFM N/A
ROA(3y)-1.71%
ROA(5y)3.32%
ROE(3y)-3.59%
ROE(5y)6.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y9.88%
F-ScoreN/A
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.28
Altman-Z 1.09
F-ScoreN/A
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-441.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.48%
EPS Next Y53.85%
EPS Next 2Y41.45%
EPS Next 3Y21.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.31%
Revenue growth 3Y2.75%
Revenue growth 5Y12.4%
Sales Q2Q%16.03%
Revenue Next Year15.03%
Revenue Next 2Y19.63%
Revenue Next 3Y16.04%
Revenue Next 5YN/A
EBIT growth 1Y-203.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.68%
EBIT Next 3Y36.76%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A